GLP-1 medicines like Ozempic, Wegovy, and Zepbound – popular across the US, help you shed pounds, but only if taken properly.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

His goal weight is 240 pounds. Weight-loss drugs aren’t always the solution: He tried a weight-loss drug for a couple of months but stopped because it didn’t help him lose weight and had side effects.

In Q2, it brought in $11.3 billion in sales, 36% higher than a year prior, and it cranked up its annual revenue guidance for ...

Some business leaders might be tested in having to respond to the different challenges and crisis situations that have ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Northcape Capital’s Fleur Wright may have missed out in the early AI and GLP-1 investor frenzy, but she made other good calls ...

Discover why Quipt, a company with strong growth potential and undervalued stock, is a compelling investment opportunity ...

Most telling though, the results that show that the overall obesity rate in the U.S. has not changed significantly in a ...

Oprah Winfrey was the first Black woman Whitney Trotter saw on TV –– and the first television figure having conversations that affected young Black girls like her.

A broader market trend observed ever since the Fed announced its September cut rate has been the volatility in the ...